This non-interventional, cross-sectional survey and retrospective review will evaluate the medical resource utilization and burden of illness in patients who have persistent symptoms of schizophrenia despite receiving adequately dosed antipsychotic treatment and who have not had an acute exacerbation in the 3 months prior to enrolment. Medical records will be reviewed for a minimum of 3 months and up to 12 months prior to screening. Data collection at a single visit will include rating scales and questionnaires that reflect the clinical status and the quality of life of the patients and the economic impact of schizophrenia.
Study Type
OBSERVATIONAL
Enrollment
1,431
Unnamed facility
Epping, New South Wales, Australia
Unnamed facility
Everton Park, Queensland, Australia
Unnamed facility
Brno, Czechia
Unnamed facility
Brno, Jihormoravsky Kraj, Czechia
Unnamed facility
Hradec Králové, Czechia
Unnamed facility
Olomouc, Czechia
Unnamed facility
Pilsen, Czechia
Unnamed facility
Prague, Czechia
Unnamed facility
Prague, Czechia
Unnamed facility
Prague, Czechia
...and 97 more locations
Medical resource utilization (in-/out-patient hospital services, community-based day service, other health care contacts) of patients with persistent symptoms of schizophrenia
Time frame: in the 3 to 12 months prior to screening
Level/severity of schizophrenia symptoms: Clinical rating scales scores (PANSS, CGI-S, PSP, WoRQ, NSA-4, HoNOS)
Time frame: Observational visit Day 1
Patient health-related quality of life (HRQoL) questionnaires
Time frame: Observational visit Day 1
Caregiver's burden as assessed by questionnaires
Time frame: Observational visit Day 1
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.